Sharekhan has given Buy recommendation for Sanofi India with a target price of Rs. 9249 in its research report issued on Feb 23, 2021
Sharekhan’s research report on Sanofi India
Sanofi India (Sanofi) reported a weak performance for the quarter with results missing estimates, though numbers are not comparable with previous quarters. Strong performance of top 10 brands which have dominant share in their respective segments augurs well and provides visibility on growth ahead. Sanofi has recommended dividend per share of Rs. 365 for CY2020, which translates into healthy dividend yield of ~4.5%. Better growth prospects, strong balance sheet with no debt, minimal capex, and healthy cash position are the key positives.